Abstract: A wearable display device according to one or more embodiments of the present invention includes: a substrate; a first sensing unit on the substrate; and a display unit arranged on the first sensing unit and including a light emitting element that emits first light to a front side to display an image and emits second light to a rear side facing the substrate, the first sensing unit being configured to measure a bio-signal generated from a user's body using the second light reflected from the user's body.

Abstract: Disclosed herein is a method of preparing a catalyst having Pt—Pd dispersed in polymer electrolyte multilayers, suitable for use in production of hydrogen peroxide, wherein the use of the catalyst prepared by forming polymer electrolyte multilayers on an anionic resin support and performing sulfuric acid treatment and loading (insertion or attachment) of Pt—Pd particles can result in high hydrogen conversion, hydrogen selectivity and hydrogen peroxide yield for a long period of time.

Abstract: The present invention relates to a method for detecting food poisoning bacteria, and more particularly, to a method for rapidly and quantitatively isolating food poisoning bacteria contents which contaminate food and the like. The method according to the present invention is characterized by including the steps of: introducing magnetic nanoparticles which can bind to bacteria into a sample for measuring the bacteria so as to bind the magnetic nanoparticles to the bacteria; isolating the magnetic nanoparticles; passing the nanoparticles which are isolated by using magnetism through a solution having high viscosity so as to separate the magnetic nanoparticles to which bacteria are bound from magnetic nanoparticles to which no bacteria are bound; and quantifying the magnetic nanoparticles to which bacteria are bound.

Abstract: The present invention relates to a method for detecting food poisoning bacteria, and more particularly, to a method for rapidly and quantitatively isolating food poisoning bacteria contents which contaminate food and the like. The method according to the present invention is characterized by including the steps of: introducing magnetic nanoparticles which can bind to bacteria into a sample for measuring the bacteria so as to bind the magnetic nanoparticles to the bacteria; isolating the magnetic nanoparticles; passing the nanoparticles which are isolated by using magnetism through a solution having high viscosity so as to separate the magnetic nanoparticles to which bacteria are bound from magnetic nanoparticles to which no bacteria are bound; and quantifying the magnetic nanoparticles to which bacteria are bound.

Abstract: Disclosed herein is a method of preparing a catalyst having Pt—Pd dispersed in polymer electrolyte multilayers, suitable for use in production of hydrogen peroxide, wherein the use of the catalyst prepared by forming polymer electrolyte multilayers on an anionic resin support and performing sulfuric acid treatment and loading (insertion or attachment) of Pt—Pd particles can result in high hydrogen conversion, hydrogen selectivity and hydrogen peroxide yield for a long period of time.

Abstract: A method and kit for measuring a concentration of an antibiotic are provided. The method of measuring a concentration of an antibiotic includes preparing magnetic particles bound to an antibiotic, preparing silica-coated fluorescent particles to which at least one antibody of the antibiotic is bound, allowing the magnetic particles to react with the silica-coated fluorescent particles, and irradiating the reacted silica-coated fluorescent particles with laser beams.

Abstract: The present invention relates to novel piperidine derivatives having effect of inhibiting acetylcholinesterase and aggregation of ?-amyloid, Alzheimer's disease-induced protein, and treatment for Alzheimer's disease containing the same, the piperidine derivatives represented by Formula 3.

Abstract: The present invention relates to novel piperidine derivatives having effect of inhibiting acetylcholinesterase and aggregation of ?-amyloid, Alzheimer's disease-induced protein, and treatment for Alzheimer's disease containing the same, the piperidine derivatives represented by Formula 3.